{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:50:26Z","timestamp":1788601826484,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T027932\/1"],"award-info":[{"award-number":["MR\/T027932\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijbiomac.2024.132655","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:05:26Z","timestamp":1716591926000},"page":"132655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P1","title":["Developing a synergistic rate-retarding polymeric implant for controlling monoclonal antibody delivery in minimally invasive glaucoma surgery"],"prefix":"10.1016","volume":"272","author":[{"given":"Mengqi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brihitejas","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Xin","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Latefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijbiomac.2024.132655_bb0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132655_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cts.12660","article-title":"Translating minimally invasive glaucoma surgery devices","volume":"13","author":"Lee","year":"2020","journal-title":"Clin. Transl. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132655_bb0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/17469899.2017.1335597","article-title":"Microinvasive glaucoma surgery: an evidence-based assessment","volume":"12","author":"Schehlein","year":"2017","journal-title":"Expert Rev. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ICU.0000000000000457","article-title":"Complications of micro-invasive glaucoma surgery","volume":"29","author":"Yook","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132655_bb0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coph.2012.08.001","article-title":"Monoclonal antibody therapeutics: history and future","volume":"12","author":"Buss","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7861\/clinmedicine.17-3-220","article-title":"Developments in therapy with monoclonal antibodies and related proteins","volume":"17","author":"Shepard","year":"2017","journal-title":"Clin. Med. (Lond.)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.132655_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09273940590951034","article-title":"Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature","volume":"13","author":"Okada","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preteyeres.2008.11.005","article-title":"Therapeutic monoclonal antibodies in ophthalmology","volume":"28","author":"Rodrigues","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2024.132655_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/vop.12843","article-title":"Medical anti-glaucoma therapy: beyond the drop","volume":"24","author":"Miller","year":"2021","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2017.01.025","article-title":"Stabilizing two IgG1 monoclonal antibodies by surfactants: balance between aggregation prevention and structure perturbation","volume":"114","author":"Wang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12551-017-0361-8","article-title":"Heat denaturation of the antibody, a multi-domain protein","volume":"10","author":"Akazawa-Ogawa","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0060","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.ijbiomac.2022.08.063","article-title":"Bevacizumab encapsulation into PLGA nanoparticles functionalized with immunouteroglobin-1 as an innovative delivery system for atherosclerosis","volume":"221","author":"De Negri Atanasio","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132655_bb0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1248\/bpb.b16-00437","article-title":"Development of a sustainable release system for a Ranibizumab biosimilar using poly(lactic-co-glycolic acid) biodegradable polymer-based microparticles as a platform","volume":"40","author":"Yusuke Tanetsugu","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jop.2010.0158","article-title":"Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model","volume":"27","author":"Pan","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjophthalmol-2018-312055","article-title":"Synthetic biodegradable alternatives to the use of the amniotic membrane for corneal regeneration: assessment of local and systemic toxicity in rabbits","volume":"103","author":"Ramachandran","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0090","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.2147\/IJN.S272750","article-title":"PLGA nanoparticle platform for trans-ocular barrier to enhance drug delivery: a comparative study based on the application of oligosaccharides in the outer membrane of carriers","volume":"15","author":"Jiang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1049\/iet-nbt.2012.0012","article-title":"In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin","volume":"7","author":"Hussein","year":"2013","journal-title":"IET Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/ICU.0b013e3281108000","article-title":"Drug delivery methods for posterior segment disease","volume":"18","author":"Hsu","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.132655_bb0105","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1167\/iovs.16-21334","article-title":"Evaluation of the toxicity of intravitreally injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response","volume":"58","author":"Thackaberry","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0110","doi-asserted-by":"crossref","first-page":"213024","DOI":"10.1016\/j.bioadv.2022.213024","article-title":"3D-printed reservoir-type implants containing poly(lactic acid)\/poly(caprolactone) porous membranes for sustained drug delivery","volume":"139","author":"Korelidou","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123857","article-title":"Effect of cold plasma treatment on polylactic acid and polylactic acid\/poly (ethylene glycol) films developed as a drug delivery system for streptomycin sulfate","volume":"235","author":"Rafique","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijbiomac.2022.05.116","article-title":"Characterization of active and pH-sensitive poly(lactic acid) (PLA)\/nanofibrillated cellulose (NFC) films containing essential oils and anthocyanin for food packaging application","volume":"212","author":"Zabidi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jbm.b.34121","article-title":"Using poly(l-lactic acid) and poly(varepsilon-caprolactone) blends to fabricate self-expanding, watertight and biodegradable surgical patches for potential fetoscopic myelomeningocele repair","volume":"107","author":"Tatu","year":"2019","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.132655_bb0130","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1208\/s12249-018-1089-x","article-title":"Sustained release of poorly water-soluble drug from hydrophilic polymeric film sandwiched between hydrophobic layers","volume":"19","author":"Kevadiya","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132655_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0376-7388(01)00652-4","article-title":"Characterization and permeation of microporous poly(\u03b5-caprolactone) films","volume":"198","author":"Lin","year":"2002","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0140","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.msec.2016.01.014","article-title":"Pore formation mechanism of porous poly(DL-lactic acid) matrix membrane","volume":"61","author":"Phaechamud","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132655_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12033-018-0084-5","article-title":"PCL-based composite scaffold matrices for tissue engineering applications","volume":"60","author":"Siddiqui","year":"2018","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2016.04.003","article-title":"PLA composites: from production to properties","volume":"107","author":"Murariu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.actbio.2018.07.040","article-title":"Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity","volume":"78","author":"Sousa","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0160","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/IJN.S296527","article-title":"A multiepitope peptide, rOmp22, encapsulated in chitosan-PLGA nanoparticles as a candidate vaccine against acinetobacter baumannii infection","volume":"16","author":"Du","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpb.2018.11.003","article-title":"Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles","volume":"133","author":"Kabiri","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132655_bb0170","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/10837450.2021.1931886","article-title":"Impact of nanosizing on the formation and characteristics of polymethacrylate films: micro- versus nano-suspensions","volume":"26","author":"Yousaf","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jconrel.2023.08.029","article-title":"In situ forming risperidone implants: effect of PLGA attributes on product performance","volume":"361","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132655_bb0180","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.132655_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2008.09.061","article-title":"Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles","volume":"368","author":"Son","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(00)00347-3","article-title":"Salt and cosolvent effects on ionic drug loading into microspheres using an O\/W method","volume":"70","author":"Ahmad Al-Maaieh","year":"2001","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.132655_bb0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/02652040400015387","article-title":"The mechanism of surface-indented protein-loaded PLGA microparticle formation: the effects of salt (NaCl) on the solidification process","volume":"21","author":"Chen","year":"2004","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/10837450.2019.1673407","article-title":"Dexamethasone loaded PLGA nanoparticles for potential local treatment of oral precancerous lesions","volume":"25","author":"Rencber","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.132655_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.132655_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132655_bb0215","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/21691401.2016.1243545","article-title":"Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation","volume":"45","author":"Pandit","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.132655_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijpharm.2016.01.020","article-title":"Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges","volume":"499","author":"Ramazani","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0225","series-title":"The Protein Protocols Handbook","first-page":"1775","article-title":"Analysis of IgG fractions by electrophoresis","author":"Page","year":"2009"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.132655_bb0230","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1038\/s41598-019-49715-8","article-title":"Development of polymer blends based on PVA:POZ with low dielectric constant for microelectronic applications","volume":"9","author":"Aziz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.proeng.2013.05.124","article-title":"Thermal stability of PCL\/PLA blends produced by physical blending process","volume":"59","author":"Patr\u00edcio","year":"2013","journal-title":"Proc. Eng."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132655_bb0240","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/acs.molpharmaceut.0c00515","article-title":"Poly(caprolactone)-based coatings on 3D-printed biodegradable implants: a novel strategy to prolong delivery of hydrophilic drugs","volume":"17","author":"Stewart","year":"2020","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0245","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab14ff","article-title":"3D printed dual macro-, microscale porous network as a tissue engineering scaffold with drug delivering function","volume":"11","author":"Dang","year":"2019","journal-title":"Biofabrication"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132655_bb0250","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/02772240802607386","article-title":"Sorption and mobility of polyethylene glycol (PEG 4000) in tropical soils","volume":"91","author":"Castanho","year":"2010","journal-title":"Toxicol. Environ. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132655_bb0255","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/ma00187a007","article-title":"Surface and bulk phase separation in block copolymers and their blends. Polysulfone\/polysiloxane","volume":"21","author":"Patel","year":"1988","journal-title":"Macromolecules"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.132655_bb0260","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.16-19585","article-title":"Biocompatibility and pharmacokinetic analysis of an intracameral polycaprolactone drug delivery implant for glaucoma","volume":"57","author":"Kim","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/1735-3327.330875","article-title":"Drug release kinetics and biological properties of a novel local drug carrier system","volume":"18","author":"Shafiei","year":"2021","journal-title":"Dent. Res. J. (Isfahan)"},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0270","first-page":"12","article-title":"Release kinetics \u2013 concepts and applications","volume":"8","author":"Paarakh","year":"2018","journal-title":"Int. J. Pharm. Res. Technol."},{"key":"10.1016\/j.ijbiomac.2024.132655_bb0275","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.132655_bb0280","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1021\/mp3001952","article-title":"Polymeric modification and its implication in drug delivery: poly-epsilon-caprolactone (PCL) as a model polymer","volume":"9","author":"Dash","year":"2012","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.132655_bb0285","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/pat.222","article-title":"In vitro study on the drug release behavior from Polylactide-based blend matrices","volume":"13","author":"Cai","year":"2002","journal-title":"Polym. Adv. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.132655_bb0290","doi-asserted-by":"crossref","first-page":"718","DOI":"10.31635\/ccschem.022.202101726","article-title":"Visualization of macrophase separation and transformation in immiscible polymer blends","volume":"5","author":"Wu","year":"2023","journal-title":"CCS Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.132655_bb0295","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.progpolymsci.2011.09.001","article-title":"Phase separation induced ordered patterns in thin polymer blend films","volume":"37","author":"Xue","year":"2012","journal-title":"Prog. Polym. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024034603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024034603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T18:42:15Z","timestamp":1735670535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024034603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":59,"alternative-id":["S0141813024034603"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132655","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a synergistic rate-retarding polymeric implant for controlling monoclonal antibody delivery in minimally invasive glaucoma surgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132655"}}